Cargando…
Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
This cross-sectional study assesses pharmacy participation in the 340B Drug Pricing Program following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods.
Autores principales: | Lin, John K., Li, Pengxiang, Doshi, Jalpa A., Desai, Sunita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206190/ https://www.ncbi.nlm.nih.gov/pubmed/35977245 http://dx.doi.org/10.1001/jamahealthforum.2022.1435 |
Ejemplares similares
-
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022
por: Nikpay, Sayeh, et al.
Publicado: (2023) -
Challenges for Managed Care from 340B Contract Pharmacies
por: Fein, Adam J.
Publicado: (2016) -
Outcomes of the 340B Drug Pricing Program: A Scoping Review
por: Knox, Ryan P., et al.
Publicado: (2023) -
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
por: Mulligan, Karen, et al.
Publicado: (2021) -
Factors Associated with Antimicrobial Drug Use in Medicaid Programs
por: Li, Pengxiang, et al.
Publicado: (2014)